Galectin Therapeutics | GALT - Capital Ordinaire

Prix De L'Action
3.03
Variation Quotidienne
-0.08 -2.57%
Mensuellement
8.21%
Annuel
89.38%
Q1 Prévisions
2.89




Capital Ordinaire Changement Date
AbbVie USD 1.77B 1.75B 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Galectin Therapeutics USD 61K 0 2023-12
Gilead Sciences USD 1.24B 1000K 2025-12
Immunic USD 8K 4K 2024-06
Incyte USD 198.46M 2.33M 2025-12
Merck USD 2.49B 15.79M 2025-09